SCHEMBL4069786

SCHEMBL4069786

C1CC(C2CCNC2)C1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL791582 1.00
SCHEMBL15927761 1.00
SCHEMBL1037843 0.94 ALDH1A1 (0.47)
SCHEMBL22540086 0.94 ALDH1A1 (0.47)
SCHEMBL14620877 0.94 ALDH1A1 (0.47)
SCHEMBL24912524 0.94 ALDH1A1 (0.47)
SCHEMBL14772 0.94 ALDH1A1 (0.47)
SCHEMBL6426932 0.94 ALDH1A1 (0.47)
SCHEMBL165540 0.94 ALDH1A1 (0.47)
SCHEMBL5114077 0.94 ALDH1A1 (0.47)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-116157392-A Compounds targeting RNA binding proteins or RNA modification proteins 雷多纳治疗公司 2023-05-23 CN disclosed
WO-2022076383-A1 SULFONANILIDE AND BENZYLSULFONYL DERIVATIVES, AND COMPOSITIONS AND METHODS THEREOF Lysoway Therapeutics, Inc. (US) 2022-04-14 WO disclosed
EP-1317445-B1 CHEMOKINE RECEPTOR BINDING HETEROCYCLIC COMPOUNDS ANORMED INC (CA) 2009-03-11 EP disclosed
US-6362201-B1 ANTIINFLAMMATORY AGENTS; ANTIALLERGENS MERCK & CO., INC. 2002-03-26 US disclosed